VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹87 Cr | ₹80 Cr | ₹77 Cr | ₹73 Cr | ₹58 Cr |
What is the latest Sundry Debtors ratio of VIMTA LABS ?
| Year | Sundry Debtors |
|---|---|
| Mar2024 | ₹87 Cr |
| Mar2023 | ₹80 Cr |
| Mar2022 | ₹77 Cr |
| Mar2021 | ₹73 Cr |
| Mar2020 | ₹58 Cr |
How is Sundry Debtors of VIMTA LABS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2024 | ₹87 Cr | 8.76 | |
| Mar2023 | ₹80 Cr | 3.96 | |
| Mar2022 | ₹77 Cr | 4.74 | |
| Mar2021 | ₹73 Cr | 26.99 | |
| Mar2020 | ₹58 Cr | - | |
Compare Sundry Debtors of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,583.2 Cr | -6.5% | -2.7% | 18.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -6.5% |
-2.7% |
18.2% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses